Metabotropic
glutamate receptors (mGluRs) are critically involved in the maintenance of long-term potentiation (LTP) (Reymann and Matthies, 1989; Behnisch et al., 1991; lzumi et al., 1991; Bashir et al., 1993) . In order to assess further the physiological role of MGluRs in LTP, we injected freely moving rats with the recently available, competitive mGluR antagonist (R,S)-a-methyl-4-carboxyphenylglycine (MCPG) intraventricularly and recorded extracellularly the population spike (PS) as well as the field excitatory postsynaptic potential (fEPSP) of the granule cells of the dentate gyrus in response to stimulation of fibers of the perforant path. MCPG was administered in two concentrations (A = 20 mm/5 Al; B = 200 mu/5 ~1) either 30 min prior to or 5 min after LTP induction. Sodium chloride infusion served as a control. Normal synaptic transmission was not altered by MCPG. However, the mGluR antagonist inhibited LTP in a concentrationdependent manner. Concentration A did not influence the potentiation shortly after the tetanus. In the PS, short-term potentiation (STP), which is decremental in its time course, occurred normally, but in contrast to controls the potentiation declined back to baseline values after 2-3 hr. This dose also reduced the posttetanic increase in the slope function of the fEPSP, and led to a time course of potentiation similar to that for the PS. Concentration B completely abolished the tetanus-induced potentiation. This block was similar to that obtained for the NMDA antagonist 2-amino-5-phosphonopentanoate (AP5). Both MCPG concentrations had no influence on the time course of preestablished LTP. These effects seem to be due to the action of the (+)-isomer of MCPG, since intracerebroventricular application of the (-)-isomer was without effect on the duration and magnitude of LTP. In addition, we were interested in the mGluR subtypes involved in the blocking mechanism of MCPG. lS,BR-aminocyclopentane-1,3-dicarboxic acid (ACPD)-activated PPI hydrolysis in hippocampal slices was competitively inhibited by MCPG at a concentration of 1 mM or higher. In contrast, this concentration of MCPG did not affect the reduction of forskolin-stimulated CAMP formation by ACPD. These results corroborate recent findings that mGluRs are required for the induction of LTP in CA1 and CA3 in vitro (Bashir et al., 1993; Sergueeva et al., 1993) and in vivo (Riedel and Reymann, 1993) . The process of STP is found to be independent of mGluR activation.
At very high concentrations MCPG may also block other glutamate receptors, for instance, the NMDA receptor, other mGluR subtypes, or it may act unspecifically.
However, our biochemical data suggest that MCPG acts as an antagonist on mGluR subtypes linked to PPI hydrolysis (i.e., mGluR1 and mGluR5) in hippocampal LTP in vivo.
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Long-term potentiation (LTP) is a long-lasting enhancement of synaptic transmission evoked by brief high-frequency stimulation of synaptic pathways (Bliss and Lomo, 1973; Bliss and Lynch, 1988) or by pairing presynaptic activity with postsynaptic depolarization (Wigstrom and Gustafsson, 1986; Bindman et al., 1988) . This form of activity-dependent synaptic plasticity is widely used as a model to investigate the cellular mechanisms of learning and memory. It is widely accepted that LTP consists of a superimposition of various processes, in which ionotropic receptors play a substantial role in both induction and maintenance of LTP at glutamatergic synapses. Furthermore, a number of intracellular enzyme-regulated cascades modulated by the activation of G-protein<oupled metabotropic glutamate receptors (mGluRs) have been identified as contributing to longlasting synaptic changes (Bliss and Collingridge, 1993; Reymann, 1993) . These mGluRs are either linked to the stimulation of phosphoinositide (PPI) hydrolysis (mGluR1 + mGluR5) or negatively coupled to adenylate cyclase activity (mGluRZ-mGluR4, mGluR6 + mGluR7), as has been described recently (Sladeczek et al., 1985; Nicoletti et al., 1986; Sugiyama et al., 1987; Palmer et al. , 1989; Nakanishi, 1992; Tanabe et al., 1992) . Some kinds ofglutamate analogs, such as quisqualate, ibotenate, 1 -aminocyclopentane-1,3-dicarboxic acid (ACPD), (2S,l'S,2'S)-carboxycyclopropyl) glycine (L-CCG-I), and (2S,11R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine (DCG-IV), appear to be selective agonists for this glutamate receptor subtype in the mammalian CNS Sugiyama et al., 1989; al Nakagawa et al., 1990; Schoepp et al., 1990a; Porter et al., 1992; Shinozaki and Ishida, 1992) . At present there is only preliminary evidence that activation of mGluRs also activates protein kinase C (PKC), which enables the late phases of LTP (Lovinger et al., 1987; Reymann et al., 1988) . Direct evidence for a link of mGluR to the activation of PKC exists only for cultured striatal neurons (Manzoni et al., 1990) .
Few mGluR antagonists have been investigated in their capacity to prevent LTP in the hippocampus of rodents. Initial experiments using the nonspecific mGluR antagonist 2-amino-4-phosphonobutyrate (AP4) selectively inhibited the maintenance of LTP in a manner similar to that found after block of PKC (Reymann et al., 1988; Reymann and Matthies, 1989; Colley et al., 1990) . Similar results were obtained with the more selective antagonist 2-amino-3-phosphonopropionate (AP3) Izumi et al., 1991; Behnisch and Reymann, 1993) . In support of these antagonist studies, application of the selective mGluR agonist ACPD (Palmer et al., 1989; Desai and Corm, 199 1) increases the amplitude of LTP (McGuiness et al., 199 la,b; Behnisch and Reymann, 1993) and may enable STP-inducing high-frequency trains to elicit LTP (Aniksztejn et al., 1992) . Even an induction of a late and stable form of LTP without the short-term component Collingridge, 1992, 1993) by application ofACPD in the absence of a tetanus was described, although the appropriate conditions for this phenomenon are not yet fully understood (Behnisch and Reymann, 1993) .
Most recently, investigations
with the selective and competitive mGluR antagonist (RS)-cu-methyl-4-carboxyphenylglycine (MCPG) have proved that the coactivation of NMDA receptors and mGluRs is required to elicit a stable and long-lasting LTP in CA1 and CA3 neurons in vitro (Bashir et al., 1993; Sergueeva et al., 1993) . In addition, we provided preliminary evidence that MCPG was also able to block LTP in dentate gyrus neurons (Riedel and Reymann, 1993) .
To characterize further the function of mGluRs in the mechanisms of LTP, we addressed the following questions using MCPG. (1) Is the activation of mGluRs during brief high-frequency shocks required to elicit LTP in the dentate gyrus in vivo or is it possible to inhibit preestablished LTP by posttetanic application of MCPG? (2) Does MCPG inhibit different phases of LTP in a concentration-dependent manner? (3) Which mGluR subtypes are involved in the block of LTP in response to drug treatment?
We here provide compelling evidence that MCPG, depending on the concentration, blocks different phases of potentiation in the dentate gyrus in vivo. Low doses selectively block LTP, whereas higher concentrations are found to inhibit the tetanusinduced STP as well. Moreover, these effects are related to the selective block of mGluR 1 and mGluR5, since MCPG was found to block PPI hydrolysis selectively, leaving inhibition of CAMP formation intact.
Materials and Methods
Animals. One hundred and fortv-six male Wistar rats, weighing 300-400 gm, were examined. After chronic implantation, animals were housed individuallv with free access to water and food pellets under a 12/12 hr day/night cycle. For measurements we transferred the rats into special test cages (40 x 40 x 50 cm) with an equilibration period of 12-15 hr. Water and food were available ad hbitum.
Chronic preparation of electrodes and cannulas. For the chronic implantation of the electrodes, rats were anesthetized with pentobarbitone (40 mg/kg, i.p.) and mounted in a stereotaxic frame. The skin was removed and selective holes were drilled into the skull for the specific implantation of electrodes and cannulas relative to bregma. A bipolar stimulation electrode was placed in the perforant path (c, -0.69; kO.41) and a monopolar recordina electrode was lowered into the granule cell layer of the dentate gyrus of the right hemisphere (c, -0.28; 1,O. 18; Fig.  1 ).
'The depth of the electrodes was adjusted such that the population spike (PS) amplitude (difference between the first positive and negative deflection) was maximal. The laminar profile of the evoked potentials was used as a guide to determine the aoorooriate depth. Two stainless steel screws, which served as reference kiectrode and electrical ground, were fixed on the contralateral skull above the frontal and parietal cortex, respectively. The free ends of the electrodes were inserted into a rubber socket and cemented to the head with dental acrylic. In addition, a cannula was implanted into the lateral ventricle of the right hemisphere for drug application. Rats were allowed 5-7 d in their home cages to recover from surgery.
Measurements in freely moving animals. At the beginning of the test session the implanted electrodes were connected to flexible cables. The recorded signals from the microelectrodes were led through a swivel commutator, amplified using a differential amplifier (band pass 0.1 Hz to 10 kHz), and transformed via an A/D interface (CED 1401, Cambridge Electronic Design) to store data on a PC disk.
At the beginning of each experiment, input-output curves were determined to assess the maximum of the PS amplitudes or the fEPSP slope functions (see Fig. 2 for detailed description of field recordings). Five test stimuli (biphasic pulses, 0.1 msec half-wave duration, interpulse interval of 4 set) were applied with varying stimulation strength and averaged subsequently. Prior to tetanic stimulation, a baseline was recorded for 30 min, during which the test stimulus intensity was set a level that evoked a PS amplitude of 40% of the maximum. Brief tetanic stimulation (10 bursts of 15 stimuli, 200 Hz, 0.2 msec duration, interburst interval of 10 set) was administered at test stimulus current through the same stimulation electrode. To avoid behavioral influences on the evoked potentials, tetanic stimulation was applied only when rats were at rest (Buszaki et al., 1981; Hargreaves et al., 1990) . Posttetanic recordings lasted up to 24 hr.
All animals were tested twice with an interval of 1 week. In one test session, the vehicle was injected, whereas in the other one MCPG was applied. The sequence of measurements was randomized to avoid serial effects. At the end of the experiment animals were decapitated and the brains were removed for histological verification of the position of electrodes and cannulas (Fig. 1 ).
Drugs and drug application. Two stock solutions of (RS+methyl-4-carboxyphenylglycine (MCPG) (Tocris Neuramin, Bristol, UK) were dissolved in equimolar NaOH (1 M; Sigma, St. Louis, MO) and small aliquots were stored at -20°C. Solution A contained 0.208 mg ofMCPG (20 mM/5 J), and solution B, 2.08 mg (200 m&5 PI), per aliquot, respectively. Before use the drug was further diluted 50-fold by adding saline (0.9% sodium chloride: Fluka. Buchs, Switzerland). Sodium chloride (vehicle) served for control application. Both solutions had a pH of 7.0. MCPG and the vehicle were injected intracerebroventricularly by means of a microsyringe (injection time, 5 min) at a volume of 5 ~1 either 30 min prior to or 5 min following tetanic stimulation. An effective concentration of MCPG at brain levels was assessed to be approximately 50 fin (concentration A) or approximately 500 PM (concentration B), if one assumes an equal distribution and the brain volume to be 2 ml. If applied pretetanically, baseline measurements continued for 0.5 hr, recording at 5 min intervals. This ensured that the mGluR antagonist had no influence on normal transmission. To corroborate this finding further, a group of animals received MCPG without a following tetanization.
To determine the duration of the efficacy of MCPG to block mGluRs, a group of rats was tested in their capacity to express LTP 24 hr after drug application. Additionally, we tested whether posttetanic application 5 min after tetanic stimulation influences the time course of preestablished LTP. To differentiate the effects of the (+)-and the (-)-isomer of MCPG we also injected the (-)-MCPG (Tocris Neuramin) in a series of animals. The preparation of the solutions was identical to that described for the racemate. Only one concentration (1.04 mg per aliquot) was tested.
The results of intracerebroventricular injection of the mGluR antagonist were compared to the effect ofNMDA receptor antagonists. Therefore, 2-amino-5-phosphonopentanoic acid (APS; Tocris Neuramin, Bristol, UK) was dissolved in sodium chloride (0.9%) prior to application. AP5 (0.024 mg) was injected intracerebroventricularly by means of a microsyringe (injection time, 5 min) at a volume of 5 ~1 30 min prior to tetanic stimulation. Thereafter, the effective concentration of AP5 at brain levels was assessed to be approximately 50 PM.
Measurement of PPI hydrolysis in brain slices. Inositol phospholipid hydrolysis was determined by measuring the accumulation of 'H-inositol monophosphate ('H-InsP) in the presence of Li+, as described previously by Nicoletti et al. (1986) . In brief, hippocampal slices were preincubated with 3 &i/ml of myo-2-3H-inositol (specific activity, 16.5 Ci/mmol) for 24 hr, rinsed extensively with prewarmed Krebs-Henseleit buffer (equilibrated with 95% 0,/5% CO, to pH 7.4), and then stimulated with truns-ACPD in the presence of 10 mM Li+ at 37°C for 30 min, whereas MCPG, when present, was added 1 min prior to ACPD application.
All chemicals except MCPG and lS,3R-ACPD were purchased from Sigma (St. Louis, MO).
Measurement ofcAMPformation in brain slices. Formation of CAMP wasdetermined by quantitativeassignment offorskohn-StimulatedcAMP using a radioimmunoassay (Casabona et al., 1992; Gennazzani et al., 1993) . Hippocampal slices were incubated for 35-45 min in KrebsHenseleit buffer (equilibrated with 95% 0,/S% CO, to pH 7.4). Small 40 ~1 aliquots of gravity-packed slices, previously transferred into polyethvlene tubes. were incubated 20 min prior to drug treatment. mGluR
The reaction (release of 3H-inositol phosphates from membrane phospholipids) was terminated by addition of ice-cold methanol/water (1: I). After further addition of chloroform and water, phases were separated, and the 'H-InsP present in the aqueous phase was separated by anion exchange chromatography and quantified according to Berridge et al. (1982) .
The supematant was diluted in water (1:lO) and used for quantitative determination of the CAMP content by radioimmunoassay (commercially available NEC 033, New England Nuclear-DuPont). Parallel samples were solubilized with 0.5 M NaOH for assessment of the protein content, as described by Lowry et al. (195 1) . The protein concentration was found to be highly stable in various samples within the same experiment.
All chemicals except MCPG and 1 S,3R-ACPD were purchased from Sigma (St. Louis, MO).
Statistical analysis. Comparison between groups was calculated statistically by means of the Mann-Whitney U test (P < 0.05).
Results

MCPG and normal transmission
In the first series of experiments we investigated the effect of MCPG on normal synaptic transmission in viva. Test animals received 5 ~1 of the drug intracerebroventricularly and were monitored for 24 hr after applying test stimuli, which elicited 40% of the maximal PS amplitude before treatment. As shown in Figure 2 , we found no concentration-dependent change in baseline recordings during 24 hr. The PS amplitude remained stable at levels of 100%. Therefore, it seems unlikely that MCPG directly influences the excitability of postsynaptic neurons or presynaptic transmitter release under normal conditions in the investigated pathway.
Vehicle application and duration of LTP To assess further the possible influences of the solvent in which MCPG was diluted prior to application, we injected rats with a vehicle solution of NaCl. Figure 3 summarizes the results. It clearly indicates that the vehicle does not alter normal transmission in its magnitude and duration during baseline recordings as well as tetanus-induced LTP. We found an increase in PS amplitude, due to the high-frequency trains, up to 250%, which slowly declines to 180% 24 hr posttetanus. Posttetanitally, the PS amplitude, measured as the difference between the first positive and negative deflection, increases up to 250-300%. This enhancement persists for 24 hr.
These results ensure that the vehicle has no influence on the induction and maintenance of LTP, and further suggest that alterations that may occur under MCPG treatment are directly linked to the effects of the drug.
While recording from the somatic layer of the granule cells in the dentate gyrus, we also recorded the population tEPSP as the maximum slope between the baseline potential and the peak of the first positive wave (Fig. 4C) . We found a significant increase in the population fEPSP slope function of 20%, which also lasted up to 24 hr.
Effects of MCPG on LTP agonists were added 2 min before forskolin. MCPG, when present, was added 15 min prior to ACPD. Another incubation of 15 min followed. Addition of ice-cold 0.8 M HCIO, (final volume, 1 ml) terminated the reaction. Samples were then sonicated for 10-l 5 set (Branson Sonifter B-12 at maximal intensity) and stored at 4°C. Before centrifugation at low speed on the next day, we added the samples to 110 ~1 of 2 M K,CO,.
term potentiation (STP) (Malenka, 199 1; Bliss and Collingridge,  Drug application 30 min prior to tetanization also does not alter the PS amplitude evoked by test stimuli during baseline mea-1993) lasted for 2-3 hr, after which the PS amplitude was back at baseline levels. The recorded PS amplitude then remained surement (Fig. 4) . Brief tetanic stimulation induced a prostable at baseline levels. The amplitude of the posttetanic ponounced potentiation up to 250-300% only in group A, where tentiation was in a range comparable to the one found in vehiclethe low concentration of MCPG was applied. This potentiation declined back to baseline levels in 2-3 hr and no recovery occurred within 24 hr. This decremental phase, defined as short- It is clearly evident that no change in PS occurs after MCPG application. In the first trace (b) the markers (ml, m2, m3) were inserted to demonstrate the points of measurement of the lEPSP slope and PS amplitude. The steepness of the first positive deflection between ml and m2 was used to measure the slope function of the fEPSP, whereas the difference between the first positive (~22) and negative (~3) deflection was calculated as PS amplitude. This mode of measurement was also applied for all other traces shown in subsequent figures. treated rats (Fig. 3) . A statistically significant difference exists between the MCPG-treated and the vehicle-treated group after 2.5 hr (* in Fig. 4A ; p < 0.05). Original traces recorded at different time points during the experiment support this observation (Fig. 4E) .
With reference to this effect, it is of particular interest to concentrate on changes of the slope function of the population EPSP due to MCPG injection. Figure 40 summarizes the results for the low MCPG doses. Obviously, only a 10% increase in the fEPSP slope occurred after tetanic stimulation. The time course of the potentiation was similar to the one recorded for the PS. Two hours after the high-frequency shocks, the tEPSP declined back to baseline levels. Group comparison revealed significant differences between controls and drug-treated animals from 2.5 hr on (* in Fig. 40 ; p < 0.05). Surprisingly, 24 hr after tetanus, the lEPSP dropped to 80%. We have no conclusive explanation for this observation.
Intracerebroventricular injection of the high concentration of MCPG 30 min prior to tetanic stimulation completely abolishes the potentiation (Fig. 4&F) . A very small increase (20-30%) in PS amplitude was recorded up to 15 min posttetanically. Afterward, responses to test stimuli fell back to baseline levels and remained stable over 4 hr. Figure 4F shows original traces recorded from dentate granule cells at different time points either prior to or after tetanization. They also indicate that shortly after the high-frequency train a small increase in PS amplitude occurs, which is normally of short duration. In order to determine the time course of the effectiveness of the mGluR antagonist, we also applied MCPG 24 hr prior to tetanization (data not shown here). We found only a slight difference in the time course of LTP as compared to the vehicleinjected animals. This difference was not statistically significant. Shortly after tetanus the PS amplitude increases up to 250% and declines to potentiated values of 180% during 2 hr. Then the LTP remained stable at this level. We never observed a decline back to baseline levels, as seen in the MCPG group. . In A, a pronounced posttetanic potentiation occurred, which had the same magnitude as observed for the vehicle group (Fig. 3) . The potentiation lasted for approximately 2-3 hr with its peak briefly after the tetanus, and a steady decay back to baseline levels. A significant difference exists between the vehicle and the low MCPG group 2.5 hr posttetanically (Mann-Whitney U test, p i 0.05). According to a recent report (Bliss and Collingridge, 1993) , this time course of potentiation might represent the STP component. Application of the IO-fold higher MCPG concentration completely blocks both LTP and STP in the dentate gyrus in vivo (B) . These data indicate a concentration-dependent action of MCPG. Higher concentrations seem to block some other receptors, although MCPG has a high affinity for mGluRs . In the C and D, measures of the population fEPSPs are shown for both the vehicle-treated (C, n = 6) and low MCPG-treated (D, n = 6) groups. The time course of the fEPSP shows a small but persistent potentiation of 20% after tetanus in controls. The time course of the IEPSP potentiation in the MCPG-treated group resembles that of the PS. Shortly after tetanization the slope was potentiated, and declined back to baseline over 2 hr. Significant differences between controls and MCPG-treated animals are indicated by asterisks induction of LTP at perforant path-dentate gyrus synapses in viva requires the activation of mGluRs. Once activated, a block of mGluRs did not change the time course of established LTP. Moreover, these data suggest that normal cellular functions were not influenced by MCPG. It seems likely then that the complete block of potentiation in the highconcentration group was due to a block of the NMDA glutamate receptor subtype and not due to an influence on subsequent intracellular events.
1989) others have failed to inhibit preestablished LTP by applying the PKC antagonists H-7 and polymyxin B 60 min after tetanization (Colley et al., 1990 ) as well as K-252 and staurosporine 60 or 180 min posttetanically (Matthies et al., 1991) . Thus, it seems reasonable to ask whether the injection of an mGluR antagonist shortly after tetanic stimulation inhibits late phases of LTP. We conducted a series of experiments in which we applied 5 ~1 of MCPG 5 min posttetanically. (Fig. 4B) . Therefore, one might suspect that MCPG in addition to its mGluR antagonism also inhibits NMDA receptors. The fact that high concentrations of MCPG were required for this blockade suggests a concentration dependence of this effect, and further indicates that the affinity of the drug is high for mGluRs and lower for NMDA receptors.
evidence that the activation of mGluR during tetanic stimulation is required to induce a long-lasting LTP.
Effect of the (-)-MCPG isomer on LTP
Recently, it was shown by Jane et al. (1993) that the active isomer of MCPG was the (+) form. We therefore analyzed whether the (-)-isomer of MCPG was without effect on induction and maintenance of LTP. (-)-MCPG, at 0.104 mg/5 ~1, was injected intracerebroventricularly 30 min prior to tetanic stimulation. As shown in Figure 6 , no alteration in the time course of LTP was observed. High-frequency shocks induced a stable and long-lasting increase in the PS amplitude with no difference from the vehicle-treated group. These results support the view that the (+)-MCPG was the active isomer, and further indicate that all monitored effects of the racemic form were due to the action of (+)-MCPG.
Effect of AP5 on LTP induction
It is well known that NMDA receptor activation is required for the induction of LTP in the hippocampus in vitro (Collingridge et al., 1988) and in vivo (Morris et al., 1986 ). As we found a complete block of LTP due to the intracerebroventricular injection of high doses of MCPG, we investigated the effect of AP5, an NMDA receptor antagonist, for a more detailed comparison.
As indicated in Figure 7 , AP5 (n = 5) completely blocks the induction of LTP in a manner similar to that described for the high concentration of MCPG. No potentiation of the PS amplitude occurred in response to tetanic stimulation. Comparing this effect with the MCPG data, one would suspect that the high concentration of MCPG also, at least partially, blocks NMDA receptors.
Efects of MCPG on PPI hydrolysis in hippocampal slices
Since electrophysiological experiments indicate that MCPG selectively blocks mGluRs, we analyzed which mGluR subtypes were antagonized by MCPG. This is of particular interest because in the dentate gyrus several different mGluR subtypes are present (Abe et al., 1992; Tanabe et al., 1992; Ohishi et al., 1993a,b) . As summarized in Figure 8 , we found that ACPD-induced PPI hydrolysis was attenuated by MCPG in a concentrationdependent fashion, most clearly evident at concentrations of 1 mM or higher. These data suggest that MCPG acts as a competitive antagonist of the mGluR1 and/or mGluR5 subtypes.
Efects of MCPG on mGluR subtypes negatively coupled to CAMP formation To assess further whether inhibition of other mGluR subtypes that are negatively linked to CAMP formation could also contribute to the inhibition of LTP, we analyzed the effect of MCPG on forskolin-stimulated CAMP formation using a concentration of MCPG (1 mM) that clearly blocks PPI hydrolysis in the same preparation.
We found (Fig. 9 ) that ACPD (100 PM) attenuated the forskolin-stimulated (30 WM) CAMP formation by up to 50%. This inhibition was not affected by the application of MCPG (I mM), although this concentration potently blocked PPI hydrolysis (Fig.  8) . These results provide conclusive evidence that MCPG predominantly blocks mGluRs coupled to PPI hydrolysis in hippocampal slice preparations. However, a significant disinhibition of the CAMP formation at higher concentrations of MCPG cannot be excluded.
Discussion
Long-term potentiation (LTP) in the hippocampus Long-term potentiation as a form ofactivity-dependent synaptic plasticity is widely accepted as a model to investigate the cellular mechanisms of learning and memory. It is a widespread phenomenon within the limbic forebrain, which shows striking differences between pathways. However, the hippocampal for- . Action of MCPG on truns-ACPD-attenuated, forskolin-induced CAMP formation in hippocampal slices. Forskolin-stimulated CAMP formation was inhibited by the activation of mGluRs due to application of IS,3R-ACPD. Administration of MCPG has no effect on ACPD-dependent inhibition of CAMP production at a concentration that is effective in blocking ACPD-induced PPI hydrolysis (I mM). All measurements were done in triplicate. For details of the biochemical procedures, see Materials and Methods.
mation is the region with the lowest threshold for producing LTP and expresses the strongest and longest-lasting potentiation (Racine et al., 1983) . Expression of LTP in the dentate gyrus depends, in part, upon the number of afferents activated by the stimulation train (McNaughton et al., 1978) , upon the activation of NMDA receptors during brief high-frequency tetanization (Collingridge et al., 1983; Harris et al., 1984; Morris et al., 1986) , and upon the behavioral state of the animal (Buszaki et al., 198 1; Hargreaves et al., 1990; Huang et al., 1992) . Additionally, NMDA receptor-independent LTP also exists, especially in hippocampal CA3 (Harris and Cotman, 1986; Teyler, 1990, 1992; Zalutsky and Nicoll, 1990; Aniksztejn and BenAri, 199 1; Weisskopf et al., 1993) . Although there is a simultaneous increase in fEPSP slope and PS amplitude after tetanization (Bliss and Gardner-Medwin, 1973; Anderson et al., 1980; Klaucnik and Phillips, 199 I) , the EPSP potentiation is small compared to PS potentiation (Bliss and Gardner-Medwin, 1973; Klaucnik and Phillips, 199 1) . We found that although the potentiation of the fEPSP was not high, it remained stable under our experimental conditions for 1 d or more.
Multiple mGluRs Metabotropic glutamate receptors (mGluRs) have recently been discovered as a new family of G-protein+oupled receptors (for review, see Schoepp and Conn, 1993) , and activation of a postsynaptic G-protein is involved in LTP in hippocampal CA1 (Ballyk and Goh, 1993) . Applying the selective mGluR agonist trans-ACPD, mGluRs were found to be linked to multiple second messenger systems. Molecular cloning studies have revealed at least seven different mGluR subtypes (Masu et al., 1991; Abe et al., 1992; Nakanishi, 1992; Tanabe et al., 1992 ) from which mGluR 1 and mGluR5 are coupled to the phosphoinositide (PPI) hydrolysis via phospholipase C (Palmer et al., 1989; Schoepp et al., 1990a,b; Conn and Desai, 199 1) . In contrast, activation of mGluR2-mGluR4, mGluR6, and mGluR7 decrease forskolin-stimulated CAMP formation (Tanabe et al., 1992) . Additionally, basal CAMP levels are increased after mGluR activation (Schoepp et al., 1992; Winder and Conn, 1992) and mGluR activation modulates several ion channels (Lester and Jahr, 1990) . Very recently, it was shown that mGluRs in addition upregulate postsynaptic protein synthesis via the phosphatidylinositol-coupled second messenger system (Weiler and Greenough, 1993) and activate phospholipase D via an AP3-resistant mechanism (Boss and Conn, 1992; Holler et al., 1993) .
It is well known that L-AP3 as a mGluR antagonist in LTP studies acts on mGluRs linked to phosphoinositide breakdown. This hydrolysis is potently inhibited by L-AP3 (Schoepp et al., 1990a,b) as well as by MCPG in hippocampal slice preparations (present results) and cortical pyramidal cells . Interestingly, MCPG does not affect forskolin-stimulated CAMP formation at concentrations that clearly suppress PPI hydrolysis in the hippocampus (present results). Although an effect on CAMP-coupled mGluRs at higher concentrations cannot be excluded here, higher doses of MCPG may also lead to unspecific effects, which in turn may influence the action of mGluR-coupled second messenger systems. It was until now unclear whether MCPG also acts on other G-protein-coupled receptors. Indirectly, MCPG block of mGluRs may modulate other transmitter receptors as well via polysynaptic mechanisms. Detailed information about such influences are not so far available.
In contrast to this report, there is recent evidence that MCPG is also an effective antagonist of mGluRs negatively coupled to CAMP formation. Similar concentrations of MCPG as reported here (1 mM) were shown to disinhibit forskolin-stimulated CAMP formation in guinea pig cortical slices, an effect proposed to be mediated by presynaptically located mGlu autoreceptors (socalled L-AP4 receptors) . Moreover, trans-ACPD-facilitated, Ca*+ -dependent glutamate release was blocked by MCPG in cerebrocortical synaptosomes (SanchezPrieto et al., 1993) and MCPG was reported to block long-term depression (LTD) in the striatal slice preparation via a presynaptic mechanism (Lovinger, 1993) .
MCPG and the physiology of mGluRs Beside these biochemical data, ACPD application has uncovered a variety of effects of mGluRs on membrane ion fluxes and synaptic events, such as depolarization and excitation (Curry et al., 1987; Charpak et al., 1990; Ishida et al., 1990 Ishida et al., , 1993 Stratton et al., 1990; Salt and Eaton, 1991) as well as the inhibition of Ca2+-dependent K+ currents resulting in a decrease of the afterhyperpolarization (Stratton et al., 1989; Baskys et al., 1990) that normally follows action potentials or trains of action potentials, or a hyperpolarization (Harvey et al., 199 1) . With respect to the mechanisms of LTP, ACPD was found to potentiate NMDA-induced responses (Collingridge et al., 1988; Aniksztejn et al., 199 1; Ben-Ari et al., 1992) possibly via PKC and/or Ca/ calmodulin kinase II-induced phosphorylation (Kitamura et al., 1993) or to reduce synaptic excitation (Baskys and Malenka, 199 1; Pook et al., 1992) . Contrasting results were obtained by others. Whereas focal application of 1 -oleoyl-2-acetylglycerol (OAG), an activator of PKC, suppressed NMDA receptor-mediated responses in CA1 hippocampal neurons (Markram and Segal, 1992) protein kinase inhibitors, such as staurosporine and K-252b, did not affect potentiation of NMDA responses by ACPD (Harvey and Collingridge, 1993) . Additionally, ACPD was described to induce LTP-like phenomena without previous activation of NMDA receptors Collingridge, 1992, 1993) or to facilitate electrically induced LTP (Otani and Ben-Ari, 199 1; McGuinnes et al., 1992; Behnisch and Reymann, 1993) . It thus seems possible that both activation or inhibition of mGluRs may influence the synaptic transmission of glutamatergic synapses. To test whether mGluRs contribute to normal synaptic transmission, we delivered the drug intracerebroventricularly and recorded the field PS amplitude under baseline conditions for up to 24 hr. Neither in the low nor in the high concentration of MCPG was any change observed in extracellularly recorded potentials compared to the preceding baseline level. We therefore conclude that MCPG has no influence on normal synaptic transmission, that is, on presynaptic glutamate release or postsynaptic AMPA receptor sensitivity, in the dentate gyrus of freely moving rats.
Interestingly, mGluR stimulation by lS,3R-ACPD is well known to reduce excitatory potentials at glutamatergic synapses in the hippocampus and other brain regions as well (Lovinger, 199 1; Rainnie and Shinnick-Gallagher, 1992 ). This effect is believed to be due to the activation of presynaptic mGlu autoreceptors, since ACPD does not alter current or voltage responses to exogenously applied excitatory amino acids (Baskys and Malenka, 199 1) . There is also evidence for presynaptically located mGluRs at corticostriatal synapses (Lovinger et al., 1992) and in hippocampal regions (Baskys and Malenka, 1991) . The mechanism of presynaptic inhibition is still a matter of debate. One hypothesis holds that this decrease in glutamate release is mediated by the inhibition ofCa2+ channels in the axon terminal (Sahara and Westbrook, 199 1; Lonart et al., 1993) . Others stated that presynaptic activation of mGluRs, which facilitate glutamate release, is mediated by a transient increase in diacylglycerol levels mediated by mGluRs coupled to PPI hydrolysis (Goh and Ballyk, 1993; Sanchez-Prieto et al., 1993) .
Moreover, the effects of mGluR activation on hippocampal intemeurons have to be considered. ACPD may either cause large inhibitory postsynaptic potentials (IPSPs) in conjunction with tetanic stimulation, thus suggesting that mGluRs can excite inhibitory cells, which then generate large IPSPs (Miles and Poncer, 1993) or generate a long-term depression of the GABAergic inhibition, thereby enhancing synaptic excitability in the hippocampal formation (Hayashi et al., 1993; Liu et al., 1993) . However, since basal responses to test stimuli were unchanged after MCPG application, it also seems unlikely that inhibitory circuits were substantially affected by the drug. Although studies on mRNA for mGluRs revealed this glutamate receptor subtype to be strongly expressed in hippocampal inhibitory cells, further investigations are needed to determine the mGluR subspecies mediating these effects.
The fact that the basal responses of the dentate granule cells were not altered after drug application thus could be interpreted in two ways. First, as we found no alteration of basal responses to test stimuli, mGluRs seem to be less important for normal synaptic responses or the interaction is too weak to influence transmitter release or AMPA receptor sensitivity. Second, and this is with respect to inhibition of LTP, different mGluRs may be activated during different physiological activity states; that is, the high-frequency train may activate a different subset of mGluRs than normal test pulses.
Effects of MCPG on induction and maintenance of hippocampal LTP The importance of mGluRs in LTP was supported recently by Collingridge (1992, 1993) who induced a stable form of LTP without the preceding STP component in the CA1 region in vitro by activation of mGluRs via lS,3R-ACPD. Results reported by Baskys and Malenka (199 1) contrasted with those of our own laboratory (Behnisch and Reymann, 1993) . We found no effect of t-ACPD on synaptic transmission. This could be due to an age dependence of the mGluR activation, as recently shown by Trommer et al. (1993) . They found that ACPD decreases PS amplitudes in CA1 and dentate gyrus in 10-l 5-d-old rats but enhances PS amplitudes in older animals.
When combining the application of ACPD with a concomitant activation of NMDA receptors and low-frequency stimulation of afferent fibers, a long-lasting enhancement of synaptic responses in CA 1 results (Radpour and Thomson, 1992; Behnisch and Reymann, 1993) .
As was shown by Bashir et al. (1993) in CA1 in vitro and by Riedel and Reymann (1993) in the dentate gyrus in vivo, MCPG selectively impairs the long-lasting potentiation without interfering with short-term enhancement of synaptic efficacy. In the low MCPG concentration group, we found STP declining back to baseline values after 2-3 hr. Bashir and colleagues provided persuasive evidence that MCPG does not affect other glutamate receptors of the AMPA and NMDA type. It is unclear at present whether this also holds for the dentate gyrus and for all concentrations.
To evaluate in vivo effects of higher MCPG concentrations, we also delivered MCPG at a dose that was comparable (i.e., 500 PM if one assumes a uniform distribution of the drug and the brain to be 2 ml) to the one utilized by Bashir et al. Interestingly, we found a complete block of a tetanus-induced potentiation in the dentate gyrus in vivo. Since this blocking action is comparable to the one found after application of AP5, one could question the absolute selectivity of MCPG on mGluRs. Very recently, Jane et al. (1993) analyzed the stereospecific antagonism of the (+)-versus (-)-isomer of MCPG on lS,3R-ACPD-induced effects in rat thalamic and motoneurons. They convincingly showed (and we present indirect evidence here) that the (+) form is the active one, which also, at least partially, antagonizes NMDA-induced responses. Consequently, our results for the high MCPG concentration could be interpreted as a combined block of both mGluRs and NMDA receptors, thereby preventing the induction of STP and LTP. Nevertheless, others excluded the possibility of an antagonism of MCPG on NMDA receptors as they found no depressing effect of MCPG in a concentration of 1 mM on depolarizations induced by NMDA and AMPA in rat thalamic and motoneurons. However, the lower concentration (concentration A in our experiments) may selectively block mGluRs, since tetanus administration results in a short-lasting and decremental STP, which requires the activation of NMDA receptors (Collingridge et al., 1983) .
How could our results be interpreted in this context? The differences occurring could first be due to a variance in the distribution of the different mGluR subtypes in the analyzed brain structures. Second, the intracerebroventricular injection of a high concentration of drugs may result in a nonuniform distribution of the compound in the brain that may be temporarily higher in the hippocampal formation that is located close to the ventricle. One thus cannot exactly determine the effective drug concentration at the recording site. Third, a different stimulation pattern was used in this study, which may also cause such a discrepancy. The importance of the tetanization parameter on MCPG action was very recently demonstrated by Brown et al. (1994) who successfully blocked LTP in CA1 in vitro using the Bashir parameters, while providing convincing evidence that MCPG does not block CA1 LTP induced by O-burst-like tetanization. Therefore, one could suggest that mGluR activation depends on release of glutamate from the presynaptic terminal, thus reflecting a threshold for activation of different mGluR subtypes. This is corroborated by the dose-dependent inhibition of LTP by MCPG. Similarly, such a dose-dependent block of LTP was described for the NMDA receptor antagonist AP5 in hippocampal CA1 (Grover and Teyler, 1994) . Finally, such discrepancies could evolve from extrahippocampal influences, which were mostly cut in slice preparations and were left intact in freely moving animals. Similar to the concentration-dependent effect of MCPG described here, the PKC inhibitor polymyxin B produced a concentration-dependent decay of the potentiation response, and at high concentrations also blocks the initial rise of potentiation (Colley et al., 1990) . This observation was thought to be due to the ability of polymyxin B at higher doses to inhibit the Ca/ calmodulin-dependent kinase II, thereby blocking initial potentiation (Reymann et al., 1988) . Very recently a block of LTP (not STP) was demonstrated by the application of anti-phosphatidylinositol-4,5-bisphosphate antibodies, which inhibit the substrate of phospholipase C (Tsubokawa et al., 1993) . Tetanic stimulation elicited only a decremental potentiation, gradually declining back to baseline in 1 hr, thus indicating that activation of mGluRs coupled to PPI hydrolysis is essential for triggering LTP. That only a high concentration of MCPG was effective against ACPD-induced PPI hydrolysis in the present work can be explained most easily by methodical differences between the physiological in vivo approach and the biochemical slice technique.
Transient PKC activation contributes to the transformation from STP into LTP (Otani et al., 1993) , since inhibitors of PKC block different phases of hippocampal LTP (Reymann et al., 1988; Malenka et al., 1989; Colley et al., 1990; Matthies et al., 199 1; Huang et al., 1992) . Normal PKC modulation seems to be prevented by MCPG, since it effectively blocks PPI hydrolysis in hippocampal slices (present results), which is thought to be a prerequisite for PKC activation. Very recently, we found a translocation of the postsynaptic y PKC subtype but not the culp PKC into the cytosolic fraction 15 min after induction of tetanus-induced LTP in the dentate gyrus in vivo (Angenstein et al., 1994) . Whether this translocation is important for LTP to occur and whether it can be blocked by pretetanic injection of MCPG have to be evaluated in further experiments.
Earlier work on LTP has already implicated a role of glutamate receptors in postsynaptic expression of LTP (Lynch and Baudry, 1983) . A specific increase in postsynaptic non-NMDA receptor-mediated EPSPs was found due to tetanic shocks (Kauer et al., 1988; Muller et al., 1989; Nicoll et al., 1990; Perkel and Nicoll, 1993) . The increase in AMPA receptor sensitivity (Davies et al., 1989 ) is blocked by MCPG in hippocampal CA1 in vitro in a concentration similar to the high dose utilized in this study (Sergueeva et al., 1993) , thus suggesting an involvement of mGluRs in the regulation of AMPA sensitivity.
We are far from a complete understanding of the role of mGluRs in LTP processes. First of all, high-affinity, selective antagonists are still not available. Using AP3 as well as AP4, it was shown for the first time that late phases of tetanus-induced LTP depend on mGluR activation (Reymann and Matthies, 1989; Behnisch et al., 1991; Izumi et al., 1991) . Better pharmacological tools have been awaited since. Second, the relative diversity of mGluRs and their involvement in a variety of second messenger cascades has obscured a clear understanding of their basal function as well as their role in LTP. Our data suppose that possible target candidates for the action of MCPG are those mGluR subtypes coupled to phosphoinositide hydrolysis, which, by activating a protein kinase, can enhance NMDA and AMPA currents (Collingridge et al., 1988; Reymann et al., 1990; Aniksztejn et al., 1992) . Activation of these mGluRs can thus enable the induction of STP and LTP (McGuinnes et al., 199 1 a,b; Behnisch and Reymann, 1993; Otani et al., 1993) .
Our results thus support the recent suggestion, by Bashir et al. (1993) and our own group (Behnisch and Reymann, 1993) , that the activation ofboth mGluRs and NMDA receptors during delivery of the brief high-frequency bursts elicit LTP, since MCPG injection 5 min after tetanization does not alter the time course of preestablished LTP. Further investigations have to elucidate whether other second messenger pathways may be affected by MCPG application as well.
